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Abstract 
Microorganisms spread across national boundaries and the professional activities of 
clinical (medical) microbiologists are critical in minimising their impact. Clinical 
microbiologists participate in many activities, e.g. diagnosis, antibiotic therapy and 
there is a need for a set of professional standards for Europe with a common 
curriculum, to build upon the current strengths of the specialty and to facilitate the 
free movement of specialists within the European Union.  Such standards will also 
better highlight the important contribution of clinical microbiologists to healthcare. 
There is a move to larger centralised microbiology laboratories often located off-site 
from an acute hospital, driven by the concentration of resources, amalgamation of 
services, outsourcing of diagnostics, automation, an explosion in the range of staff 
competencies and accreditation. Large off-site centralised microbiology laboratories 
are often distant to the patient and may not facilitate the early detection of microbial 
spread. Ultimately, the needs of patients and the public are paramount in deciding on 
the future direction of clinical microbiology.  Potential conflicts between integration 
on an acute hospital site and centralization can be resolved by a common set of 
professional standards and a team-based approach that puts patients first. 
 
 
Key words: clinical microbiology, professional standards, curriculum, 
centralization, outsourcing, integration 
 
 
Introduction  
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The ease with which we move across continents alters our perception of distance and 
we are increasingly part of a global community. This applies to us and to our 
microorganisms such as H1N1 influenza virus, methicillin-resistant Staphylococcus 
aureus (MRSA), human immunodeficiency virus (HIV), tuberculosis and hyper 
virulent strains of Clostridium difficile 027. Their success in causing epidemics is 
influenced by the effectiveness of early detection, therapy and control.   
 
A key medical specialty in this regard, is Clinical Microbiology (CM), referred to as 
Medical Microbiology in some countries, but is there a broad consensus within 
Europe of what CM involves? CM is a combination of many activities including 
amongst other things the synthesis and reporting of microbiology laboratory results 
and clinical consultation.  Many of the components are interdependent and must be 
underpinned by agreed professional standards. Furthermore, deficiencies in one 
aspect, e.g. laboratory diagnosis can impair quality in another, e.g. clinical 
consultation.    
 
CM has evolved over the last three decades from one that was largely laboratory-
based and dominated by bacteriology to a complex mix of diagnostic, therapeutic, 
scientific, epidemiological and preventative activities. During that time, enormous 
changes have impacted on CM and infectious diseases (ID), including dramatically 
increased rates and novel complex mechanisms of antibiotic resistance rendering an 
increased number of bacteria virtually untreatable, more patients highly susceptible to 
infection, the application of molecular microbiology to rapid diagnosis and new 
infections, e.g. Legionella pneumophila, Borrelia burgdorferi, Clostridium difficile, 
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Helicobacter pylori disease, HIV, Hepatitis C, SARS and West Nile virus, all 
described in the last 30-35 years.  
 
Professional Standards 
Given these changes, a set of European professional standards for the medical 
specialty of CM is needed for three main reasons. Although, professional standards 
for related disciplines such as ID are of course also important, they are not the subject 
of this article.  
 
Firstly, it is necessary to discuss and define the professional standards required in 
delivering optimal microbiological support to colleagues and patients in all health 
care settings, thus providing a clear common professional identity. Presently there is 
no common European tradition with regards to the balance between laboratory-based 
diagnostic microbiology and bedside consultation and infection prevention and 
control. 
 
Secondly, common professional standards will enable us to formulate a common 
European curriculum. A European Directive ensures the free movement of medical 
specialists within the European Union (EU) where the specialty in question is fully 
recognised (Council Directive 93/16/EEC of 5 April 1993 to facilitate the free 
movement of doctors and the mutual recognition of their diplomas, certificates and 
other evidence of formal qualifications; http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31993L0016:EN:HTML). 
Individual countries may also require the medical specialist to master the official 
language of the country in which they wish to practice.  An agreed curriculum will 
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harmonise co-operation between colleagues and meet the expectations of patients and 
national health systems. Delegates from the EU in the Union of European Medical 
Specialties (UEMS) Section of Medical (clinical) Microbiology are mandated to 
design and update a curriculum for training within the EU which is supported by the 
European Society of Clinical Microbiology and Infectious Diseases (ESCMID).  Non-
EU countries are welcome to be involved and use this curriculum.  Professional 
standards and training programmes must be subject to quality control, be peer 
reviewed with regular and mutual inspections and be accredited by delegates from the 
UEMS Section of Medical Microbiology rather than by national governments but 
with input from the public in the future.  
 
Thirdly, a common professional identity is required for communication purposes 
ranging from quality issues in healthcare to the training of future clinical 
microbiologists. Most members of the public and many healthcare professionals are 
unclear about the role of clinical microbiologists, unlike for example with 
neurosurgeons, orthopaedic surgeons and paediatricians, whose contribution and role 
is well defined. Most politicians, administrators and some colleagues mistakenly view 
CM like clinical chemistry, i.e. a laboratory discipline consisting solely of analysing 
samples. The establishment of a set of professional standards would address this 
professional recognition gap.  Such professional standards must cover an integrated 
range of functions from microbiology laboratory diagnosis to research and 
development in microbiology and infections (Table 1). 
 
Members of the public often view any infection as a medical failure due to 
inadequacies in CM and related specialties, not realizing that some infections, 
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especially in very vulnerable patients, are difficult to prevent and virtually inevitable.  
This view can only be countered by the highest professional standards that are 
recognizable and acceptable to the public.   
 
Challenges facing CM 
CM must also adapt to new challenges which include changing professional practice, 
technological advances in the laboratory and information technology (IT).  In CM 
there is much discussion on what can provide the better service - an on-site hospital 
clinical microbiology laboratory with close links between the clinical microbiologists 
and other specialists in consultation, or a large multidisciplinary laboratory located 
off-site at a distance from a hospital. This second option concentrates technical 
resources on a single site with diagnostic automation and IT, but with the risk of only 
processing microbiology specimens. There is no one correct option for all 
circumstances but CM must not become a bystander to a largely analytic service 
without clinical and consultative aspects. When assessing which model is appropriate, 
it is important to understand what professional standards in CM should support.  
These are – 
• Delivering safe, rapid, efficient and effective care to all patients.  
• Creating a microbiologically safe environment for patients and 
health care workers in hospitals and in other healthcare facilities. 
• Assessing and counteracting the evolution of new and existing diseases, and 
the rapid increase in antimicrobial resistance.  
 
Current trends in CM include concentration of resources (the formation of larger 
microbiological units from the closing of smaller units), amalgamation of services 
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(the formation of multidisciplinary laboratory facilities), outsourcing of microbiology 
laboratory diagnostics, automation of sample handling and diagnostics, 
accreditation of services and an explosion in microbiology laboratory staff 
competencies with greater sub-specialisation of skills and tasks.   
 
The formation of larger microbiology laboratories, through concentration and/or 
amalgamation, and the closure of smaller facilities may increase the range of 
diagnostics and staff competences, and increase flexibility in staffing, affordability of 
automation and perceived cost/effectiveness. However, contact with the individual 
patient and the consultative aspect of the services may be lost as much energy will be 
devoted to the logistics of services, e.g. transport of a sample and the automation of 
diagnostics. Consequently, we may lose control over the rapid spread of certain 
infections with preventative measures not being implemented. Epidemiological 
monitoring is a key component of publically funded CM services to quickly identify 
changing trends to facilitate early interventions but this support is not necessarily 
provided by private organisations or consortia. 
 
Outsourcing refers to the sub-contracting of microbiology processes to a third party. 
This already partly occurs such as when specialist tests are referred to a regional or 
national reference laboratory. However, it is important to distinguish between the 
referring on of samples between professionals to enhance services and to provide 
appropriate expertise compared with outsourcing driven solely by cost savings and 
logistics. Outsourcing may separate the three main activities of CM; analysis on one 
side and synthesis and consultation on the other with a lack of input as to what is 
being done and why.  Accreditation is driven by patient safety, political pressures and 
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a desire for harmonization of services. It can enhance professional standards but often 
excessively focuses on technical aspects with delayed improvements in service 
development. 
 
The range of competences among staff is rapidly increasing, e.g. staff exclusively 
involved in flow cytometry or antimicrobial susceptibility testing. Medically trained 
staff work with biomedical scientists, immunologists, physicists, biologists, molecular 
microbiologists, statisticians and others. The need for many competences drives 
concentration and amalgamation and may be seen by some as a substitute for medical 
staff rather than as complementary. Finally, despite advantages such as cost-
effectiveness, automation may lead to a loss of expertise, and overdependence on 
technology, at the expense of clinical acumen. 
 
Rationalization and professional standards 
The roles of the clinical microbiologist are linked and complementary.  For example, 
the laboratory diagnosis of MRSA surgical site infection requires technical skills, 
clinical consultation, advice on antimicrobial therapy, infection prevention and 
control measures, and the findings may challenge the efficacy of antibiotic 
stewardship measures.  All components must be included in any agreement or 
contract between the provider (public or private off-site laboratory) and user (acute 
hospital, primary care facility).   
 
The multidisciplinary or large-scale microbiological laboratory on a green-field or 
non-hospital site is often characterized by the provision of services on a regional (or 
national) scale with large volumes of specimens collected from many different 
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sources. Logistics become all-important, clinical liaison is difficult because of 
distances, with non-participation by CM in patient care and due to the scale of 
operation, the needs of the individual patient are lost. 
 
The integrated CM service is usually part of a hospital and provides a comprehensive 
service including diagnostics (analysis and synthesis), clinical consultation and 
infection prevention and control to that hospital, and to the surrounding community, 
e.g. general practitioners and nursing homes.  Consultants in CM work with and assist 
other medical specialists, most particularly ID, internal medicine, paediatrics, surgery 
and public health but must not be separated from the laboratory.  Some small hospital-
based CM laboratories are finding it increasingly difficult to afford developments in 
modern CM because of the absence of large numbers of specimens or the need to 
invest upstream in the laboratory.  For example PCR for MRSA before surgery leads 
to earlier decolonisation with greater efficiencies and potential cost savings for 
surgery, although sometimes difficult to quantify, but these are not repatriated to the 
microbiology laboratory. 
 
The availability of critical but preliminary results can be communicated by staff as 
part of an integrated CM service to allow interim therapeutic or infection prevention 
and control action for which detailed knowledge of the local circumstances and 
facilities is essential. Hospitals located in the north and west of Europe were more 
likely to examine blood cultures more than once a day and just over 40% of 
laboratories conducted daily ward rounds by CMs or ID physicians to advise on 
therapy, more common in the north (58%) and west (49%)[1]. However, there was no 
analysis in terms of the size of the departments surveyed.  Requests for telephone 
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advice came most frequently from the medical specialties, neurosurgery and intensive 
care in an Irish hospital but those relating to infection prevention and control had 
increased in the later years [2]. The clinical microbiologist also acts as a “gate-
keeper” in the approval of requests for testing, contributing to cost-effective CM 
services. 
 
Large centralised microbiology laboratories have the potential and expertise to assess 
new technologies and to combine basic with translational research because of the 
professional skill mix, e.g. medical doctors, doctoral scientists, immunologists, 
molecular biologists, etc.  In a large regional French laboratory, ribosomal sequencing 
of brain abscess material identified 49 bacterial species compared with 14 by culture 
[3] but the apparent failure to try and interpret the significance of the additional 
species in individual patients and how this extra information affected antimicrobial 
chemotherapy and clinical outcome, means the true role of this technology is not yet 
clear.  
 
Large centralised microbiology laboratories can designate specific staff to prioritize 
quality assurance issues but quality per se may then not be embedded in all staff. A 
review of staff in the UK suggests that there may be an optimal number of staff, i.e. 
less than 30 which maximizes efficiency and staff satisfaction [4].   
 
High throughput and an extended working day are potentially easier in large 
centralised or off-site laboratories because the increased numbers of staff provide 
more flexibility. Nonetheless, there may be a failure to reflect individual patient 
needs, and a lack of urgency.  A large complement of staff may facilitate a 24 hour 
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service, resulting in quicker results and a more extensive range of tests but this may 
lead to unnecessary testing with the failure to prioritize tests because there is not full 
integration with a CM service.  Some of the positive features of both models are 
highlighted in Table 2. 
 
Conclusions 
Ultimately, the needs of patients and the public are paramount in the future of CM.  
Potential conflicts between integration and specialization can be resolved by a 
common set of professional standards and a team-based, flexible approach. However, 
the separation of CM from patient care risks undermining the diagnosis and 
management of infection in all patients, and the infrastructure that currently facilitates 
infection prevention and antibiotic stewardship must be preserved.  A rational and 
safe option should include integrated comprehensive CM laboratories taking the lead 
in providing services for the individual patient, usually on a hospital site as the sickest 
patients are located there, assisted by specialized and regional laboratories, which 
may be off site. In the Netherlands, the National Health Care Inspectorate has 
concluded that the current structure for CM should be maintained in the interests of 
patient safety and that widespread outsourcing is not necessary or acceptable [5]. 
Finally, the European professional societies, ESCMID and UEMS, must lead in 
defining the appropriate professional standards for CM and in addressing the 
challenges ahead while at the same time recognizing differences in regional and 
national approaches to service delivery. 
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